BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33215742)

  • 1. An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2.
    Shin E; Jin H; Suh DS; Luo Y; Ha HJ; Kim TH; Hahn Y; Hyun S; Lee K; Bae J
    EMBO J; 2020 Dec; 39(24):e104719. PubMed ID: 33215742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity.
    Carles A; Trigo-Gonzalez G; Cao Q; Cheng SG; Moksa M; Bilenky M; Huntsman DG; Morin GB; Hirst M
    Cancer Res; 2020 Sep; 80(17):3480-3491. PubMed ID: 32641414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease.
    Pilsworth JA; Cochrane DR; Neilson SJ; Moussavi BH; Lai D; Munzur AD; Senz J; Wang YK; Zareian S; Bashashati A; Wong A; Keul J; Staebler A; van Meurs HS; Horlings HM; Kommoss S; Kommoss F; Oliva E; Färkkilä AE; Gilks B; Huntsman DG
    J Pathol Clin Res; 2021 May; 7(3):243-252. PubMed ID: 33428330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FOXO1 mitigates the SMAD3/FOXL2
    Secchi C; Benaglio P; Mulas F; Belli M; Stupack D; Shimasaki S
    J Transl Med; 2021 Feb; 19(1):90. PubMed ID: 33639972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Oncogenic FOXL2 C134W Mutation Is a Key Driver of Granulosa Cell Tumors.
    Llano E; Todeschini AL; Felipe-Medina N; Corte-Torres MD; Condezo YB; Sanchez-Martin M; López-Tamargo S; Astudillo A; Puente XS; Pendas AM; Veitia RA
    Cancer Res; 2023 Jan; 83(2):239-250. PubMed ID: 36409821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of FOXL2 C134W Mutation Status by a Novel BaseScope In Situ Hybridization Assay is Highly Sensitive and Specific for Adult Granulosa Cell Tumors.
    Hammer PM; Wang A; Beard C; Zdravkovic S; Tenney T; Liang B; Das I; Bremer R; Wang LC; McCluggage WG; Stewart CJR; Howitt BE
    Mod Pathol; 2023 Nov; 36(11):100318. PubMed ID: 37634867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant FOXL2
    Weis-Banke SE; Lerdrup M; Kleine-Kohlbrecher D; Mohammad F; Sidoli S; Jensen ON; Yanase T; Nakamura T; Iwase A; Stylianou A; Abu-Rustum NR; Aghajanian C; Soslow R; Da Cruz Paula A; Koche RP; Weigelt B; Christensen J; Helin K; Cloos PAC
    Cancer Res; 2020 Sep; 80(17):3466-3479. PubMed ID: 32641411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The FOXL2 mutation (c.402C>G) in adult-type ovarian granulosa cell tumors of three Japanese patients: clinical report and review of the literature.
    Takahashi A; Kimura F; Yamanaka A; Takebayashi A; Kita N; Takahashi K; Murakami T
    Tohoku J Exp Med; 2013 Dec; 231(4):243-50. PubMed ID: 24257635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?
    Pilsworth JA; Todeschini AL; Neilson SJ; Cochrane DR; Lai D; Anttonen M; Heikinheimo M; Huntsman DG; Veitia RA
    J Pathol; 2021 Nov; 255(3):225-231. PubMed ID: 34338304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic analysis of recurrent adult-type granulosa cell tumor of the ovary: Persistent preservation of heterozygous c.402C>G FOXL2 mutation.
    Yanagida S; Anglesio MS; Nazeran TM; Lum A; Inoue M; Iida Y; Takano H; Nikaido T; Okamoto A; Huntsman DG
    PLoS One; 2017; 12(6):e0178989. PubMed ID: 28594898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adult Granulosa Cell Tumor With High-grade Transformation: Report of a Series With FOXL2 Mutation Analysis.
    Fashedemi Y; Coutts M; Wise O; Bonhomme B; Baker G; Kelly PJ; Soubeyran I; Catherwood MA; Croce S; McCluggage WG
    Am J Surg Pathol; 2019 Sep; 43(9):1229-1238. PubMed ID: 31162286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of wild-type but not C134W mutant FOXL2 enhances GnRH-induced cell apoptosis by increasing GnRH receptor expression in human granulosa cell tumors.
    Cheng JC; Klausen C; Leung PC
    PLoS One; 2013; 8(1):e55099. PubMed ID: 23372819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOXL2 and TERT promoter mutation detection in circulating tumor DNA of adult granulosa cell tumors as biomarker for disease monitoring.
    Groeneweg JW; Roze JF; Peters EDJ; Sereno F; Brink AGJ; Paijens ST; Nijman HW; van Meurs HS; van Lonkhuijzen LRCW; Piek JMJ; Lok CAR; Monroe GR; van Haaften GW; Zweemer RP
    Gynecol Oncol; 2021 Aug; 162(2):413-420. PubMed ID: 34083028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Composite Serous Borderline Tumor and Adult Granulosa Cell Tumor-like Area: Is it a True Neoplastic AGCT or Tumor-like Proliferation?
    Yu J; Nie X
    Int J Gynecol Pathol; 2017 May; 36(3):265-269. PubMed ID: 27648785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transcriptional targets of mutant FOXL2 in granulosa cell tumours.
    Rosario R; Araki H; Print CG; Shelling AN
    PLoS One; 2012; 7(9):e46270. PubMed ID: 23029457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXL2 402C>G Mutation Can Be Identified in the Circulating Tumor DNA of Patients with Adult-Type Granulosa Cell Tumor.
    Färkkilä A; McConechy MK; Yang W; Talhouk A; Ng Y; Lum A; Morin RD; Bushell K; Riska A; McAlpine JN; Gilks CB; Unkila-Kallio L; Anttonen M; Huntsman DG
    J Mol Diagn; 2017 Jan; 19(1):126-136. PubMed ID: 27810330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).
    Benayoun BA; Caburet S; Dipietromaria A; Georges A; D'Haene B; Pandaranayaka PJ; L'Hôte D; Todeschini AL; Krishnaswamy S; Fellous M; De Baere E; Veitia RA
    PLoS One; 2010 Jan; 5(1):e8789. PubMed ID: 20098707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aromatase is a direct target of FOXL2: C134W in granulosa cell tumors via a single highly conserved binding site in the ovarian specific promoter.
    Fleming NI; Knower KC; Lazarus KA; Fuller PJ; Simpson ER; Clyne CD
    PLoS One; 2010 Dec; 5(12):e14389. PubMed ID: 21188138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of a FOXL2 mutation (402C→G) in the blood of adult-type granulosa cell tumor patients possessing the FOXL2 mutation.
    Lee S; Kim TH; Won M; Ko JJ; Rho J; Lee K; Bae J
    Int J Gynecol Cancer; 2010 Nov; 20(8):1341-3. PubMed ID: 21051974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.